Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0X8MZ
|
|||
| Former ID |
DIB005689
|
|||
| Drug Name |
Alvameline
|
|||
| Synonyms |
Alvameline maleate; LU-25077; LU-25109; LU-31126; LU-32181; Lu-25109M
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Alzheimer disease [ICD-11: 8A20; ICD-10: G30, G30.9; ICD-9: 331] | Terminated | [1] | |
| Company |
H Lundbeck A/S
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C9H15N5
|
|||
| Canonical SMILES |
CCN1N=C(N=N1)C2=CCCN(C2)C
|
|||
| InChI |
1S/C9H15N5/c1-3-14-11-9(10-12-14)8-5-4-6-13(2)7-8/h5H,3-4,6-7H2,1-2H3
|
|||
| InChIKey |
RNMOMKCRCIRYCZ-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 120241-31-8
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | In vivo muscarinic cholinergic mediated effects of Lu 25-109, a M1 agonist and M2/M3 antagonist in vitro. Psychopharmacology (Berl). 1998 Jun;137(3):233-40. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.